{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:09:21Z","timestamp":1761822561622},"reference-count":50,"publisher":"American Society for Microbiology","issue":"16","license":[{"start":{"date-parts":[[2003,8,15]],"date-time":"2003-08-15T00:00:00Z","timestamp":1060905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2003,8,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>We produced and characterized a cell clone (J12#26 cells) that stably expresses Japanese encephalitis virus (JEV) cDNA, J12, which encodes the viral signal peptide, premembrane (prM), and envelope (E) proteins (amino acid positions 105 to 794). Rabbit kidney-derived RK13 cells were transfected with a J12 expression plasmid, selected by resistance to marker antibiotics, and cloned by two cycles of a limiting-dilution method in the presence of antibiotics, a procedure that prevents the successful generation of E-producing cell clones. J12#26 cells secreted virus-like particles containing the authentic E antigen (E-VLP) into the culture medium in a huge enzyme-linked immunosorbent assay-equivalent amount (2.5 \u03bcg per 10<jats:sup>4<\/jats:sup>cells) to the internationally licensed JE vaccine JE-VAX. E-VLP production was stable after multiple cell passages and persisted over 1 year with 100% expressing cells without detectable cell fusion, apoptosis, or cell death, but was suspended when the cells grew to 100% confluency and contact inhibition occurred. Mice immunized with the purified J12#26 E-antigen without adjuvant developed high titers of neutralizing antibodies for at least 7 months and 100% protection against intraperitoneal challenge with 5 \u00d7 10<jats:sup>6<\/jats:sup>PFU of JEV when examined according to the JE vaccine standardization protocol. These results suggest that the recombinant E-VLP antigen produced by the J12#26 cell clone is an effective, safe, and low-cost second-generation subunit JE vaccine.<\/jats:p>","DOI":"10.1128\/jvi.77.16.8745-8755.2003","type":"journal-article","created":{"date-parts":[[2003,7,28]],"date-time":"2003-07-28T21:36:47Z","timestamp":1059428207000},"page":"8745-8755","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":44,"title":["Stable High-Producer Cell Clone Expressing Virus-Like Particles of the Japanese Encephalitis Virus E Protein for a Second-Generation Subunit Vaccine"],"prefix":"10.1128","volume":"77","author":[{"given":"Asato","family":"Kojima","sequence":"first","affiliation":[{"name":"Department of Pathology, National Institute of Infectious Diseases, Tokyo 162-8640"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Institute of Infectious Diseases, Tokyo 162-8640"},{"name":"Biological Science Laboratory, Zeon Corporation, Kanagawa 210-0863"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Asanuma","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Institute of Infectious Diseases, Tokyo 162-8640"},{"name":"Institute of Glycotechnology, School of Engineering, Tokai University, Kanagawa 259-1292"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyokazu","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Kanonji Institute, The Research Foundation for Microbial Diseases of Osaka University, Kagawa 768-0061"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihisa","family":"Takamizawa","sequence":"additional","affiliation":[{"name":"Kanonji Institute, The Research Foundation for Microbial Diseases of Osaka University, Kagawa 768-0061"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Yasui","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Tokyo Metropolitan Institute for Neuroscience, Tokyo 183-0042, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kurata","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Institute of Infectious Diseases, Tokyo 162-8640"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"155","volume":"19","year":"2001","unstructured":"Ashok, M. S., and P. N. Rangarajan. 2001. Evaluation of the potency of BIKEN inactivated Japanese encephalitis vaccine and DNA vaccines in an intracerebral Japanese encephalitis virus challenge model. Vaccine19:155-157.","journal-title":"Vaccine"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","unstructured":"Berger E. G. 1997. The Golgi apparatus: from discovery to contemporary studies p. 1-36. In E. G. Berger and J. Roth (ed.) The Golgi apparatus. Birkh\u00e4user Verlag Basel Switzerland.","DOI":"10.1007\/978-3-0348-8876-9_1"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-0934(94)90120-1"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-69-11-2741"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.4.3095-3101.1999"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(97)00195-3"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.9.4244-4252.2000"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.12.10137-10145.1999"},{"key":"e_1_3_2_10_2","first-page":"11","volume":"267","year":"2002","unstructured":"Endy, T. P., and A. Nisalak. 2002. Japanese encephalitis virus: ecology and epidemiology. Curr. Top. Microbiol. Immunol.267:11-48.","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"e_1_3_2_11_2","unstructured":"European Agency for the Evaluation of Medical Products. 2002. Note for guidance on the use of bovine serum in the manufacture of human biological medical products. In Committee for Proprietary Medical Products (ed.) Evaluation of medicines for human use. CPMP\/BWP\/1793\/02. London England."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","unstructured":"Farquhar M. G. and H. P. Hauri. 1997. Protein sorting and vesicular traffic in the Golgi apparatus p. 63-130. In E. G. Berger and J. Roth (ed.) The Golgi apparatus. Birkh\u00e4user Verlag Basel Switzerland.","DOI":"10.1007\/978-3-0348-8876-9_3"},{"key":"e_1_3_2_13_2","first-page":"368","volume":"89","year":"1989","unstructured":"Ghosh, S. N., P. S. Sathe, S. A. Sarthi, D. Cecilia, C. N. Dandawate, S. S. Athawale, and U. Pant. 1989. Epitope analysis of strains of Japanese encephalitis virus by monoclonal antibodies. Indian J. Med. Res.89:368-375.","journal-title":"Indian J. Med. Res."},{"key":"e_1_3_2_14_2","first-page":"37","volume":"14","year":"1990","unstructured":"Grachev, V. 1990. World Health Organization attitude concerning the use of continuous cell lines as substrates for production of human virus vaccines. Adv. Biotechnol. Processes14:37-67.","journal-title":"Adv. Biotechnol. Processes"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-72-6-1323"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1999.9695"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1996.tb124960.x"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.32.6.1604-1605.1994"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(92)90177-Q"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-3527(08)60263-8"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-3527(00)55005-2"},{"key":"e_1_3_2_22_2","first-page":"2509","volume":"67","year":"1991","unstructured":"Hoshikawa, N., A. Kojima, A. Yasuda, E. Takayashiki, S. Masuko, J. Chiba, T. Sata, and T. Kurata. 1991. Role of the gag and pol genes of human immunodeficiency virus in the morphogenesis and maturation of retrovirus-like particles expressed by recombinant vaccinia virus: an ultrastructural study. J. Gen. Virol.67:2509-2517.","journal-title":"J. Gen. Virol."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-0934(01)00346-9"},{"key":"e_1_3_2_24_2","first-page":"139","volume":"267","year":"2002","unstructured":"Igarashi, A. 2002. Control of Japanese encephalitis in Japan: immunization of humans and animals, and vector control. Curr. Top. Microbiol. Immunol.267:139-152.","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.4049\/jimmunol.141.10.3606","volume":"141","year":"1988","unstructured":"Kimura-Kuroda, J., and K. Yasui. 1988. Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies. J. Immunol.141:3606-3610.","journal-title":"J. Immunol."},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-67-12-2663"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1159\/000050045"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.5.2204-2212.2001"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(97)00265-X"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.6.4925-4930.1998"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.67.3.1672-1675.1993"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(92)90526-U"},{"key":"e_1_3_2_33_2","first-page":"91","volume":"267","year":"2002","unstructured":"Kurane, I. 2002. Immune responses to Japanese encephalitis virus. Curr. Top. Microbiol. Immunol.267:91-103.","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-1702(96)01343-3"},{"key":"e_1_3_2_35_2","unstructured":"Lindenbach B. D. and C. M. Rice. 2001. Flaviviridae : the viruses and their replication p. 991-1041. In D. M. Knipe and P. M. Howley (ed.) Fields virology 4th ed. vol. 1. Lippincott Williams & Wilkins Philadelphia Pa."},{"key":"e_1_3_2_36_2","first-page":"49","volume":"267","year":"2002","unstructured":"Mackenzie, J. S., C. A. Johansen, S. A. Ritchie, A. F. Hurk, and R. A. Hall. 2002. Japanese encephalitis as an emerging virus: the emergence and spread of Japanese encephalitis virus in Australia. Curr. Top. Microbiol. Immunol.267:49-74.","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-70-8-2037"},{"key":"e_1_3_2_38_2","first-page":"105","volume":"267","year":"2002","unstructured":"Monash, T. P. 2002. Japanese encephalitis vaccines: current vaccines and future prospects. Curr. Top. Microbiol. Immunol.267:105-138.","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.4.1742-1751.2000"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2001.1048"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(91)90434-D"},{"key":"e_1_3_2_42_2","doi-asserted-by":"crossref","unstructured":"Ramboug A. and Y. Clermont. 1997. Three-dimensional structure of the Golgi apparatus in mammalian cells p. 37-62. In E. G. Berger and J. Roth (ed.) The Golgi apparatus. Birkh\u00e4user Verlag Basel Switzerland.","DOI":"10.1007\/978-3-0348-8876-9_2"},{"key":"e_1_3_2_43_2","first-page":"223","volume":"267","year":"2002","unstructured":"Roehrig, J. T., M. Layton, P. Smith, G. L. Campbell, R. Nasci, and R. S. Lanciotti. 2002. The emergence of West Nile virus in North America: ecology, epidemiology, and surveillance. Curr. Top. Microbiol. Immunol.267:223-240.","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1006\/biol.1996.0052"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1993.1064"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.7.4549-4557.1996"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00208-0"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.3.2141-2149.1998"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00037-2"},{"key":"e_1_3_2_50_2","unstructured":"World Health Organization. 1998. Requirements for the use of animal cells as in vitro substrates for the production of biologicals p. 19-52. In WHO expert committee on biological standardization. WHO Technical Report Series no. 878. World Health Organization Geneva Switzerland."},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.64.6.2788-2795.1990"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.77.16.8745-8755.2003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.77.16.8745-8755.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T18:07:22Z","timestamp":1682532442000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.77.16.8745-8755.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8,15]]},"references-count":50,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2003,8,15]]}},"alternative-id":["10.1128\/JVI.77.16.8745-8755.2003"],"URL":"https:\/\/doi.org\/10.1128\/jvi.77.16.8745-8755.2003","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8,15]]},"assertion":[{"value":"2002-12-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-05-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-08-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}